Hochschulschrift
Funtional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
194 Bl.
- Language
-
Englisch
- Notes
-
Ill., graph. Darst.
Enth. 9 Sonderabdr. aus verschiedenen Zeitschr.
Bremen, Univ., Diss., 2013
- Classification
-
Medizin, Gesundheit
Landwirtschaft, Veterinärmedizin
- Creator
-
Willenbrock, Saskia
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
- 11.06.2025, 1:51 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Willenbrock, Saskia
Other Objects (12)
Functional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Current status of dendritic cell-based tumor vaccination
Mechanism of dendritic cell-based vaccination against Leishmania major
HMGN2, a new anti-tumor effector molecule of CD8+ T cells
Isolation and characterization of Rabaptin-5, an effector molecule of the small GTPase
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Single molecule analyses reveal dynamics of Salmonella translocated effector proteins in host cell endomembranes
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
HMGB1, neuronal excitability and epilepsy
HMGB1 in inflammation and cancer
Cytotoxic effector mechanisms
WELLA EFFECTOR 10
Functional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Current status of dendritic cell-based tumor vaccination
Mechanism of dendritic cell-based vaccination against Leishmania major
HMGN2, a new anti-tumor effector molecule of CD8+ T cells
Isolation and characterization of Rabaptin-5, an effector molecule of the small GTPase
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Single molecule analyses reveal dynamics of Salmonella translocated effector proteins in host cell endomembranes
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
HMGB1, neuronal excitability and epilepsy
HMGB1 in inflammation and cancer
Cytotoxic effector mechanisms
WELLA EFFECTOR 10
Functional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Current status of dendritic cell-based tumor vaccination
Mechanism of dendritic cell-based vaccination against Leishmania major
HMGN2, a new anti-tumor effector molecule of CD8+ T cells
Isolation and characterization of Rabaptin-5, an effector molecule of the small GTPase
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Single molecule analyses reveal dynamics of Salmonella translocated effector proteins in host cell endomembranes
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
HMGB1, neuronal excitability and epilepsy
HMGB1 in inflammation and cancer
Cytotoxic effector mechanisms